Difference between revisions of "Alpha-2 plasmin inhibitor (TG2)"
| Line 46: | Line 46: | ||
|- | |- | ||
| Notes | | Notes | ||
| − | | 4 of 35 Q residues were labeled with the following reactivities: Q2 > Q21 > Q419 > Q447 | + | | 4 of 35 Q residues were labeled with the following |
| + | reactivities: Q2 > Q21 > Q419 > Q447 | ||
|- | |- | ||
| {{infobox header}} | | | {{infobox header}} | | ||
Revision as of 13:08, 17 July 2007
| Template:Infobox header| Alpha-2 plasmin inhibitor (TG2) | |
|---|---|
| Alpha-2 plasmin inhibitor (TG2) | |
| Substrate peptide name | Alpha-2 plasmin inhibitor (TG2) |
| Synonyms | Alpha-2-antiplasmin |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Extracellular; plasma |
| Swissprot ID | P08697 |
| Reactive glutamines | Q2 |
| Reactive lysines | - |
| Substrate sequence | NQEEVSP |
| Structure | No available crystal structure |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:10958788 |
| Notes | 4 of 35 Q residues were labeled with the following
reactivities: Q2 > Q21 > Q419 > Q447 |
| Template:Infobox header | | |
.png){kind=link}